(WT) - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US97717P1049
Stock: ETFs, Index Licensing, 401(k) Platform, Advisory
Total Rating 68
Risk 80
Buy Signal 1.16
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.11% |
| Yield on Cost 5y | 2.89% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 84.5% |
| Payout Ratio | 14.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.8% |
| Relative Tail Risk | -4.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 49.23 |
| Character TTM | |
|---|---|
| Beta | 1.166 |
| Beta Downside | 1.235 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.13% |
| CAGR/Max DD | 1.06 |
Description: WT January 14, 2026
WisdomTree, Inc. (NYSE:WT) is an ETF sponsor and asset manager that offers exchange-traded funds across equities, currencies, fixed income, and alternative asset classes, while also licensing its fundamentally weighted indexes to third-party product providers and supporting the inclusion of its ETFs in 401(k) plans.
As of FY 2023, WisdomTree reported approximately $110 billion in assets under management (AUM), a 15% year-over-year revenue increase driven largely by higher inflows into its fixed-income and “smart beta” equity products; however, fee compression in the broader ETF market and a rising interest-rate environment remain material risks to future growth. The firm’s core differentiator-fundamentally weighted indexing-has gained traction as investors seek alternatives to market-cap weighting, especially in a period where macro-economic uncertainty is prompting a shift toward income-focused and lower-volatility strategies.
For a deeper quantitative breakdown of WisdomTree’s valuation metrics, see the ValueRay profile.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 109.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.87 > 1.0 |
| NWC/Revenue: 42.59% < 20% (prev 48.90%; Δ -6.31% < -1%) |
| CFO/TA 0.10 > 3% & CFO 149.5m > Net Income 109.1m |
| Net Debt (644.9m) to EBITDA (172.9m): 3.73 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.3m) vs 12m ago -2.91% < -2% |
| Gross Margin: 67.59% > 18% (prev 0.72%; Δ 6687 % > 0.5%) |
| Asset Turnover: 38.78% > 50% (prev 41.39%; Δ -2.61% > 0%) |
| Interest Coverage Ratio: 5.54 > 6 (EBITDA TTM 172.9m / Interest Expense TTM 30.4m) |
Altman Z'' 2.49
| A: 0.14 (Total Current Assets 492.4m - Total Current Liabilities 282.1m) / Total Assets 1.51b |
| B: 0.15 (Retained Earnings 220.8m / Total Assets 1.51b) |
| C: 0.13 (EBIT TTM 168.5m / Avg Total Assets 1.27b) |
| D: 0.20 (Book Value of Equity 224.4m / Total Liabilities 1.10b) |
| Altman-Z'' Score: 2.49 = A |
Beneish M -2.70
| DSRI: 1.24 (Receivables 64.5m/44.9m, Revenue 493.8m/427.7m) |
| GMI: 1.06 (GM 67.59% / 71.65%) |
| AQI: 0.97 (AQ_t 0.67 / AQ_t-1 0.69) |
| SGI: 1.15 (Revenue 493.8m / 427.7m) |
| TATA: -0.03 (NI 109.1m - CFO 149.5m) / TA 1.51b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of WT shares?
As of February 10, 2026, the stock is trading at USD 15.98 with a total of 1,762,456 shares traded.
Over the past week, the price has changed by -0.50%, over one month by +18.81%, over three months by +36.69% and over the past year by +65.08%.
Over the past week, the price has changed by -0.50%, over one month by +18.81%, over three months by +36.69% and over the past year by +65.08%.
Is WT a buy, sell or hold?
has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy WT.
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the WT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18.9 | 18.4% |
| Analysts Target Price | 18.9 | 18.4% |
| ValueRay Target Price | 21.9 | 37.1% |
WT Fundamental Data Overview February 09, 2026
P/E Trailing = 20.9867
P/E Forward = 18.315
P/S = 4.4858
P/B = 5.3541
Revenue TTM = 493.8m USD
EBIT TTM = 168.5m USD
EBITDA TTM = 172.9m USD
Long Term Debt = 805.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 152.8m USD (from shortTermDebt, last quarter)
Debt = 956.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.86b USD (2.21b + Debt 956.6m - CCE 311.7m)
Interest Coverage Ratio = 5.54 (Ebit TTM 168.5m / Interest Expense TTM 30.4m)
EV/FCF = 19.16x (Enterprise Value 2.86b / FCF TTM 149.2m)
FCF Yield = 5.22% (FCF TTM 149.2m / Enterprise Value 2.86b)
FCF Margin = 30.23% (FCF TTM 149.2m / Revenue TTM 493.8m)
Net Margin = 22.10% (Net Income TTM 109.1m / Revenue TTM 493.8m)
Gross Margin = 67.59% ((Revenue TTM 493.8m - Cost of Revenue TTM 160.0m) / Revenue TTM)
Gross Margin QoQ = 74.72% (prev 55.31%)
Tobins Q-Ratio = 1.89 (Enterprise Value 2.86b / Total Assets 1.51b)
Interest Expense / Debt = 1.15% (Interest Expense 11.0m / Debt 956.6m)
Taxrate = 20.68% (10.4m / 50.5m)
NOPAT = 133.6m (EBIT 168.5m * (1 - 20.68%))
Current Ratio = 1.75 (Total Current Assets 492.4m / Total Current Liabilities 282.1m)
Debt / Equity = 2.31 (Debt 956.6m / totalStockholderEquity, last quarter 413.7m)
Debt / EBITDA = 3.73 (Net Debt 644.9m / EBITDA 172.9m)
Debt / FCF = 4.32 (Net Debt 644.9m / FCF TTM 149.2m)
Total Stockholder Equity = 412.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.57% (Net Income 109.1m / Total Assets 1.51b)
RoE = 26.49% (Net Income TTM 109.1m / Total Stockholder Equity 412.0m)
RoCE = 13.84% (EBIT 168.5m / Capital Employed (Equity 412.0m + L.T.Debt 805.1m))
RoIC = 12.47% (NOPAT 133.6m / Invested Capital 1.07b)
WACC = 7.41% (E(2.21b)/V(3.17b) * Re(10.21%) + D(956.6m)/V(3.17b) * Rd(1.15%) * (1-Tc(0.21)))
Discount Rate = 10.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.64%
[DCF Debug] Terminal Value 83.22% ; FCFF base≈133.9m ; Y1≈165.2m ; Y5≈281.4m
Fair Price DCF = 33.81 (EV 5.40b - Net Debt 644.9m = Equity 4.76b / Shares 140.7m; r=7.41% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.11 | EPS CAGR: 36.62% | SUE: 4.0 | # QB: 2
Revenue Correlation: 95.79 | Revenue CAGR: 18.36% | SUE: 2.30 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.032 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-12-31): EPS=1.13 | Chg30d=+0.199 | Revisions Net=+1 | Growth EPS=+31.9% | Growth Revenue=+30.7%
EPS next Year (2027-12-31): EPS=1.20 | Chg30d=+0.134 | Revisions Net=+3 | Growth EPS=+6.2% | Growth Revenue=+7.9%
P/E Forward = 18.315
P/S = 4.4858
P/B = 5.3541
Revenue TTM = 493.8m USD
EBIT TTM = 168.5m USD
EBITDA TTM = 172.9m USD
Long Term Debt = 805.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 152.8m USD (from shortTermDebt, last quarter)
Debt = 956.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.86b USD (2.21b + Debt 956.6m - CCE 311.7m)
Interest Coverage Ratio = 5.54 (Ebit TTM 168.5m / Interest Expense TTM 30.4m)
EV/FCF = 19.16x (Enterprise Value 2.86b / FCF TTM 149.2m)
FCF Yield = 5.22% (FCF TTM 149.2m / Enterprise Value 2.86b)
FCF Margin = 30.23% (FCF TTM 149.2m / Revenue TTM 493.8m)
Net Margin = 22.10% (Net Income TTM 109.1m / Revenue TTM 493.8m)
Gross Margin = 67.59% ((Revenue TTM 493.8m - Cost of Revenue TTM 160.0m) / Revenue TTM)
Gross Margin QoQ = 74.72% (prev 55.31%)
Tobins Q-Ratio = 1.89 (Enterprise Value 2.86b / Total Assets 1.51b)
Interest Expense / Debt = 1.15% (Interest Expense 11.0m / Debt 956.6m)
Taxrate = 20.68% (10.4m / 50.5m)
NOPAT = 133.6m (EBIT 168.5m * (1 - 20.68%))
Current Ratio = 1.75 (Total Current Assets 492.4m / Total Current Liabilities 282.1m)
Debt / Equity = 2.31 (Debt 956.6m / totalStockholderEquity, last quarter 413.7m)
Debt / EBITDA = 3.73 (Net Debt 644.9m / EBITDA 172.9m)
Debt / FCF = 4.32 (Net Debt 644.9m / FCF TTM 149.2m)
Total Stockholder Equity = 412.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.57% (Net Income 109.1m / Total Assets 1.51b)
RoE = 26.49% (Net Income TTM 109.1m / Total Stockholder Equity 412.0m)
RoCE = 13.84% (EBIT 168.5m / Capital Employed (Equity 412.0m + L.T.Debt 805.1m))
RoIC = 12.47% (NOPAT 133.6m / Invested Capital 1.07b)
WACC = 7.41% (E(2.21b)/V(3.17b) * Re(10.21%) + D(956.6m)/V(3.17b) * Rd(1.15%) * (1-Tc(0.21)))
Discount Rate = 10.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.64%
[DCF Debug] Terminal Value 83.22% ; FCFF base≈133.9m ; Y1≈165.2m ; Y5≈281.4m
Fair Price DCF = 33.81 (EV 5.40b - Net Debt 644.9m = Equity 4.76b / Shares 140.7m; r=7.41% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.11 | EPS CAGR: 36.62% | SUE: 4.0 | # QB: 2
Revenue Correlation: 95.79 | Revenue CAGR: 18.36% | SUE: 2.30 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.032 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-12-31): EPS=1.13 | Chg30d=+0.199 | Revisions Net=+1 | Growth EPS=+31.9% | Growth Revenue=+30.7%
EPS next Year (2027-12-31): EPS=1.20 | Chg30d=+0.134 | Revisions Net=+3 | Growth EPS=+6.2% | Growth Revenue=+7.9%